Changes in cerebral perfusion after acute head injury: comparison of CT with Tc-99m HM-PAO SPECT.
Technetium-99m hexamethylpropyleneamine oxime (Tc-99m HM-PAO) was successfully used with single photon emission computed tomography (SPECT) on fourteen comatose patients who had acute head injuries. The SPECT scans were correlated with computed tomography (CT) scans obtained within 24 hours of the injury. Tc-99m HM-PAO SPECT was shown to have the following advantages: It reflected perfusion changes, was more sensitive than CT in demonstrating more lesions, and demonstrated lesions at an earlier stage than those demonstrated with CT. Different types of lesions, as evidenced by cerebral perfusion changes, have been described and categorized. The lesions that had a favorable prognosis could be separated from those with an unfavorable prognosis on the basis of the findings of Tc-99m HM-PAO SPECT.
D000058:Accidental Falls; D000063:Accidents, Traffic; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging; D002560:Cerebrovascular Circulation; D003128:Coma / Q000175:diagnosis / Q000503:physiopathology; D006259:Craniocerebral Trauma / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D008297:Male; D009942:Organometallic Compounds; D010091:Oximes; D011379:Prognosis; D013667:Technetium; D019690:Technetium Tc 99m Exametazime; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods*; D014057:Tomography, X-Ray Computed
D009942:Organometallic Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D013667:Technetium